Opinion News
-
Opinion | Views | By Milind Kokje | 0 Comment | 14 Sep, 2017
The US Food & Drug Administration (USFDA) has recently approved the first gene therapy for difficult-to-treat acute lymphoblastic leukemia. The promising medical breakthrough involves g...Read more
-
Overcoming dependency on China...
Opinion | Views | By Milind Kokje | 0 Comment | 22 Aug, 2017
Conflict with China at Doklam is bound to have ripples in different areas, political and economic. Pharma sector is also one of them going by the imports from China for making drugs. Thus, ...Read more
-
Opinion | Views | By Milind Kokje | 0 Comment | 27 Jul, 2017
India’s Central Drugs Standard Control Organisation (CDSCO), the apex body for regulatory control working under the health ministry, has adopted two prong strategy to control the spre...Read more
-
Opinion | Views | By Milind Kokje | 0 Comment | 04 Jul, 2017
‘Right-to-try’ is being debated fiercely in US as the American Congress is considering a bill on the topic. It is a practice allowing patients diagnosed with terminal illnesses ...Read more
-
Opinion | Views | By Milind Kokje | 0 Comment | 19 May, 2017
Almost three months after the National Pharmaceutical Pricing Authority (NPPA) ceiling the maximum prices of cardiac stents, as expected, there have been complaints of non-compliance of the...Read more
-
Bionics potential largely untapped in India
Opinion | Features | 0 Comment | 27 Apr, 2017
Artificial limbs that can help people walk, artificial eyes that help blind people see! Who knew that original body parts can be replaced by artificial ones. Welcome to the new world of bio...Read more
-
DermTech announces new pharma collaborations
Opinion | News | By BioSpectrum Bureau | 0 Comment | 19 Apr, 2017
DermTech, Inc., the global leader in non-invasive molecular dermatology, has collaborated with two multi-national pharmaceutical companies. These two recent collaborations are further examp...Read more
